Yi Yang

2.6k total citations
116 papers, 1.9k citations indexed

About

Yi Yang is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Yi Yang has authored 116 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 32 papers in Hepatology and 30 papers in Surgery. Recurrent topics in Yi Yang's work include Hepatocellular Carcinoma Treatment and Prognosis (32 papers), Liver Disease Diagnosis and Treatment (18 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers). Yi Yang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (32 papers), Liver Disease Diagnosis and Treatment (18 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers). Yi Yang collaborates with scholars based in China, United States and New Zealand. Yi Yang's co-authors include Renzhi Wang, Wenbin Ma, En Zhang, Shangshang Qin, Yongning Li, Yujing Xin, Yong Yao, Tongguo Si, Xiang Zhou and Cun Heng He and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yi Yang

113 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Yang China 23 477 422 329 292 272 116 1.9k
Xuebin Qin United States 33 1.1k 2.4× 413 1.0× 273 0.8× 199 0.7× 225 0.8× 93 3.6k
Xiaoting Wang China 27 908 1.9× 349 0.8× 265 0.8× 56 0.2× 440 1.6× 98 2.8k
Feng Xue China 28 808 1.7× 375 0.9× 225 0.7× 128 0.4× 225 0.8× 87 2.3k
Shuping Zhao China 28 1.3k 2.8× 529 1.3× 162 0.5× 120 0.4× 599 2.2× 68 2.9k
Lan Bai China 24 743 1.6× 347 0.8× 167 0.5× 88 0.3× 191 0.7× 101 1.7k
Gregory J. Tsay Taiwan 29 663 1.4× 387 0.9× 184 0.6× 145 0.5× 209 0.8× 107 2.4k
David W. A. Beno United States 21 491 1.0× 294 0.7× 176 0.5× 250 0.9× 161 0.6× 54 1.4k
Pedro A. Ruiz Switzerland 23 1.0k 2.2× 454 1.1× 345 1.0× 113 0.4× 196 0.7× 56 2.5k
Pei Liu China 21 379 0.8× 206 0.5× 225 0.7× 130 0.4× 111 0.4× 78 1.3k
Pedro Majano Spain 31 734 1.5× 1.1k 2.6× 446 1.4× 908 3.1× 328 1.2× 59 2.8k

Countries citing papers authored by Yi Yang

Since Specialization
Citations

This map shows the geographic impact of Yi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Yang more than expected).

Fields of papers citing papers by Yi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Yang. The network helps show where Yi Yang may publish in the future.

Co-authorship network of co-authors of Yi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Yang. A scholar is included among the top collaborators of Yi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Yang. Yi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zong, Yuan, Yang Chen, Lei Li, et al.. (2025). KMO-driven metabolic reconfiguration and its impact on immune cell infiltration in nasopharyngeal carcinoma: a new avenue for immunotherapy. Cancer Immunology Immunotherapy. 74(3). 75–75. 1 indexed citations
2.
Zhou, Yanzhao, Hongcai Yang, Zhengzheng Wang, et al.. (2024). The Influence of Visceral Adiposity on Overall Survival: Exploring “Obesity Paradox” Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy. Journal of Hepatocellular Carcinoma. Volume 11. 1193–1206. 3 indexed citations
3.
Yang, Yi, et al.. (2024). Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma. Hepatology International. 18(5). 1486–1498. 5 indexed citations
4.
Xü, Ying, Zhuo Li, Yanzhao Zhou, et al.. (2023). Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma. BMC Cancer. 23(1). 1009–1009. 4 indexed citations
5.
Wang, Zhengzheng, Kun Yuan, Yi Yang, et al.. (2023). Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis. Journal of Hepatocellular Carcinoma. Volume 10. 1465–1477. 6 indexed citations
6.
Xü, Ying, Zhuo Li, Yi Yang, et al.. (2023). Association Between MRI Radiomics and Intratumoral Tertiary Lymphoid Structures in Intrahepatic Cholangiocarcinoma and Its Prognostic Significance. Journal of Magnetic Resonance Imaging. 60(2). 715–728. 8 indexed citations
8.
Zhou, Qiuzhong, Wen Li, Melvin Khee‐Shing Leow, et al.. (2023). Multidimensional conservation analysis decodes the expression of conserved long noncoding RNAs. Life Science Alliance. 6(6). e202302002–e202302002. 3 indexed citations
9.
Yang, Lin, Yi Yang, Peng Wang, et al.. (2022). PRDX6 Promotes Fatty Acid Oxidation via PLA2-Dependent PPARα Activation in Rats Fed High-Fat Diet. Antioxidants and Redox Signaling. 38(16-18). 1184–1200. 6 indexed citations
10.
Zhang, Jiong, John R. Cappiello, Yi Yang, et al.. (2021). Identification of simple arylfluorosulfates as potent agents against resistant bacteria. Proceedings of the National Academy of Sciences. 118(28). 42 indexed citations
11.
Zhou, Yanzhao, Yi Yang, Zhengzheng Wang, et al.. (2021). Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria. SHILAP Revista de lepidopterología. Volume 8. 625–644. 16 indexed citations
12.
Yang, Yi, Yi Chen, Feng Ye, et al.. (2020). Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival. European Radiology. 31(5). 3053–3064. 36 indexed citations
13.
Yang, Yi, et al.. (2020). Asymmetric synthesis of linezolid thiazolidine-2-thione derivatives via CS2 mediated decarboxylation cyclization. Tetrahedron Letters. 61(19). 151847–151847. 1 indexed citations
14.
Yang, Yi, et al.. (2019). Low-toxicity amphiphilic molecules linked by an aromatic nucleus show broad-spectrum antibacterial activity and low drug resistance. Chemical Communications. 55(30). 4307–4310. 39 indexed citations
15.
Qin, Shangshang, et al.. (2018). Synthesis and antibacterial bioactivities of cationic deacetyl linezolid amphiphiles. European Journal of Medicinal Chemistry. 155. 925–945. 34 indexed citations
16.
Wang, Mingming, et al.. (2018). Dithiocarbamates: Efficient metallo-β-lactamase inhibitors with good antibacterial activity when combined with meropenem. Bioorganic & Medicinal Chemistry Letters. 28(21). 3436–3440. 27 indexed citations
19.
Kong, Xiangyi, Jian Guan, Yi Yang, et al.. (2015). A meta-analysis: Do prophylactic antiepileptic drugs in patients with brain tumors decrease the incidence of seizures?. Clinical Neurology and Neurosurgery. 134. 98–103. 32 indexed citations
20.
Xing, Bing, et al.. (2011). Transsphenoidal microsurgery in 541 patients with Cushing's disease. Zhonghua shenjing waike zazhi. 27(9). 868–871. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026